In conclusion, this is the first study evaluating a multi-marker panel of mRNAs, including tumor cell-specific (CEA, CA125 and HE4) and epithelial-specific (EPCAM and MUC1) mRNAs in EOC patients before and after adjuvant chemotherapy. The gene discussed is WFDC2; the disease is neoplasm.